Evaluation of Systemic Exposure to VP-102 in Subjects With Molluscum Contagiosum.
Status:
Recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to determine the systemic presence or absence of
VP-102 topical film forming solution when applied to molluscum contagiosum lesions in
subjects 2 years of age or older from a single 24-hour dermal application. Treatment will
continue over the course of 3 additional 21 day intervals allowing for further evaluation of
safety, efficacy and impact on quality of life.
Phase:
Phase 2
Details
Lead Sponsor:
Verrica Pharmaceuticals Inc.
Collaborators:
Cato Research Database Integrations Instat services Paidion Research, Inc